Alvotech og Teva Pharmaceuticals hefja sölu á líftæknilyfjahliðstæðunni Simlandi í Bandaríkjunum

May 20, 2024

https://www.globenewswire.com/news-release/2024/05/21/2885215/0/is/Alvotech-og-Teva-Pharmaceuticals-hefja-s%C3%B6lu-%C3%A1-l%C3%ADft%C3%A6knilyfjahli%C3%B0st%C3%A6%C3%B0unni-Simlandi-%C3%AD-Bandar%C3%ADkjunum.html

Alvotech (NASDAQ:ALVO) og samstarfsaðili þess Teva Pharmaceuticals Ltd. tilkynntu í dag að sala væri hafin í Bandaríkjunum á Simlandi (adalimumab-ryvk), fyrstu líftæknilyfjahliðstæðunni í háum styrk með útskiptanleika við Humira sem hlotið hefur markaðsleyfi frá Matvæla- og lyfjaeftirliti Bandaríkjanna (FDA).

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.